Evidence map›Paper›PMID 31315299›Full record

ReviewToxins2019

The ADP-Ribosylating Toxins of

Rachel A Cheng, Martin Wiedmann

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A multidrug-resistantMicrobial genomics · 2023
    Article
  5. Article
  6. ABToxins · 2022
    Review
  7. The evolutionary diversification of theFrontiers in microbiology · 2022
    Article
  8. CRISPR/Cas9-Based Deletion of SpvB Gene FromFrontiers in bioengineering and biotechnology · 2022
    Article
  9. Cellular Activity ofToxins · 2021
    Article
  10. Recent Advances in the Detection of Antibiotic and Multi-Drug ResistantInternational journal of molecular sciences · 2021
    Review
  11. ADP-ribosylation systems in bacteria and viruses.Computational and structural biotechnology journal · 2021
    Review
  12. Review
  13. Article
  14. Draft Genome Sequence of the LyticMicrobiology resource announcements · 2020
    Article
  15. Genomic characterization ofMicrobial genomics · 2020
    Article
  16. Type III Secretion 1 Effector Gene Diversity AmongFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rachel A ChengDepartment of Food Science, Cornell University, Ithaca, NY 14853, USA. ram524@cornell.edu.
Martin WiedmannDepartment of Food Science, Cornell University, Ithaca, NY 14853, USA.
Cornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of pathogenic bacteria utilize toxins to mediate disease in a susceptible host. The foodborne pathogen

Indexed as

ADP Ribose TransferasesSalmonellaToxins, BiologicalAnimalsHumansADP Ribose TransferasesToxins, BiologicalADP-ribosyltransferaseArtABSalmonellaSboCSeoCSpvBtoxintyphoid toxin

Identifiers

PMID31315299
PMCPMC6669713
OpenAlexW2962038183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.